Literature DB >> 31211883

Equol inhibits growth and spore formation of Clostridioides difficile.

Y Tanaka1, S Kimura1, Y Ishii1, K Tateda1.   

Abstract

AIMS: Equol is a nonsteroidal oestrogen of the isoflavone class. We investigated the antibacterial ability of equol with respect to the growth rate, toxin production and spore-forming abilities of Clostridioides difficile BI/027/NAP1. METHODS AND
RESULTS: Isoflavones, or female hormones, were added to bacterial culture, which was grown at 35°C. The absorbance of the culture was measured at various time points for evaluating the growth inhibition. The toxin levels in the media and morphological changes were also assessed. To evaluate the influence of equol on the sporulation of C. difficile, cells were collected at various time points from the equol-supplemented culture and the number of spores was counted. Our results show that equol inhibits bacterial growth in a concentration-dependent manner. However, it does not inhibit the production of toxin by C. difficile. Other isoflavones and female hormones did not inhibit the C. difficile growth. At the 14th day, approximately 600 spores were present in the control medium and only six were seen in the equol-containing medium.
CONCLUSION: Our results suggest that equol may directly inhibit the C. difficile growth in a concentration-dependent manner and spore formation. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report on the antimicrobial ability of equol.
© 2019 The Society for Applied Microbiology.

Entities:  

Keywords:  zzm321990C. difficilezzm321990; antibacterial ability; equol; infection; isoflavones; spore formation

Mesh:

Substances:

Year:  2019        PMID: 31211883     DOI: 10.1111/jam.14353

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  4 in total

1.  Anti-bacterial and Anti-biofilm Effects of Equol on Yersinia enterocolitica.

Authors:  Hye-Rim Kim; Mi-Suk Han; Yong-Bin Eom
Journal:  Indian J Microbiol       Date:  2022-04-18

2.  Characterization and Identification of a New Daidzein Reductase Involved in (S)-Equol Biosynthesis in Clostridium sp. ZJ6.

Authors:  Yunfei Hu; Chunfang Yang; Can Song; Weixuan Zhong; Baiyuan Li; Linyan Cao; Huahai Chen; Changhui Zhao; Yeshi Yin
Journal:  Front Microbiol       Date:  2022-05-20       Impact factor: 6.064

3.  Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant Escherichia coli.

Authors:  Hye-Rim Kim; Yong-Bin Eom
Journal:  Antibiotics (Basel)       Date:  2021-02-05

Review 4.  Microbial Metabolites Determine Host Health and the Status of Some Diseases.

Authors:  Panida Sittipo; Jae-Won Shim; Yun Kyung Lee
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.